1)国立がん研究センターがん対策情報センター
2)IARC Working Group:IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Schistosomes, liver flukes and Helicobacter Pylori, Vol. 61. IARC, Lyon,1994
3)Epstein MA, Achong BG, Barr YM:Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1:702-703,1964
4)Young LS, Rickinson AB:Epstein-Barr virus : 40 years on. Nat Rev Cancer 4:757-768,2004
5)Takeuchi K, Tanaka-Taya K, Kazuyama Y, et al:Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Pathol Int 56:112-116,2006
6)Wang D, Liebowitz D, Kieff E:An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840,1985
7)Shibata D, Weiss LM:Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140:769-774,1992
8)Murphy G, Pfeiffer R, Camargo MC, et al:Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 137:824-833,2009
9)Shinkura R, Yamamoto N, Koriyama C, et al:Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan. J Med Virol 60:411-416,2000
10)van Beek J, zur Hausen A, Klein Kranenbarg E, et al:EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol 22:664-670,2004
11)Tokunaga M, Land CE:Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomarkers Prev 7:449-450,1998
12)Shibata D, Tokunaga M, Uemura Y, et al:Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139:469-474,1991
13)Uemura Y, Tokunaga M, Arikawa J, et al:A unique morphology of Epstein-Barr virus-related early gastric carcinoma. Cancer Epidemiol Biomarkers Prev 3:607-611,1994
14)Raab-Traub N, Flynn K:The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889,1986
15)Hirano A, Yanai H, Shimizu N, et al:Evaluation of epstein-barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay. Int J Gastrointest Cancer 34:87-94,2003
16)Uozaki H, Fukayama M:Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol 1:198-216,2008
17)Matsusaka K, Kaneda A, Nagae G, et al:Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res 71:7187-7197,2011
18)Tao Q, Robertson KD:Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin Immunol 109:53-63,2003
19)Iwakiri D, Sheen TS, Chen JY, et al:Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 24:1767-1773,2005
20)伊藤哲彦,徳永正義:EBウイルスとヒトがん 最近の進展 EBウイルス関連胃がんの臨床病理.日本臨牀 55:363-367,1997
21)清水則夫,渡邊健,水上美樹,他:診断・治療2.EBウイルスの核酸検出法.EBウイルス改訂第2版(高田賢蔵監修,柳井秀雄,清水則夫編),診断と治療社,pp195-201,2008